- Home
- SMHI vs BIOA Comparison
SMHI vs BIOA Comparison
Compare SMHI & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMHI
- BIOA
- Stock Information
- Founded
- SMHI 1989
- BIOA 2015
- Country
- SMHI United States
- BIOA United States
- Employees
- SMHI N/A
- BIOA N/A
- Industry
- SMHI Marine Transportation
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- SMHI Consumer Discretionary
- BIOA Health Care
- Exchange
- SMHI Nasdaq
- BIOA Nasdaq
- Market Cap
- SMHI 186.4M
- BIOA 175.7M
- IPO Year
- SMHI N/A
- BIOA 2024
- Fundamental
- Price
- SMHI $6.28
- BIOA $7.83
- Analyst Decision
- SMHI
- BIOA Hold
- Analyst Count
- SMHI 0
- BIOA 4
- Target Price
- SMHI N/A
- BIOA $9.00
- AVG Volume (30 Days)
- SMHI 66.0K
- BIOA 618.7K
- Earning Date
- SMHI 10-29-2025
- BIOA 11-06-2025
- Dividend Yield
- SMHI N/A
- BIOA N/A
- EPS Growth
- SMHI N/A
- BIOA N/A
- EPS
- SMHI N/A
- BIOA N/A
- Revenue
- SMHI $245,311,000.00
- BIOA $3,863,000.00
- Revenue This Year
- SMHI N/A
- BIOA N/A
- Revenue Next Year
- SMHI $9.97
- BIOA N/A
- P/E Ratio
- SMHI N/A
- BIOA N/A
- Revenue Growth
- SMHI N/A
- BIOA N/A
- 52 Week Low
- SMHI $3.63
- BIOA $2.88
- 52 Week High
- SMHI $8.61
- BIOA $25.30
- Technical
- Relative Strength Index (RSI)
- SMHI N/A
- BIOA 70.97
- Support Level
- SMHI N/A
- BIOA $7.25
- Resistance Level
- SMHI N/A
- BIOA $8.15
- Average True Range (ATR)
- SMHI 0.00
- BIOA 0.42
- MACD
- SMHI 0.00
- BIOA 0.18
- Stochastic Oscillator
- SMHI 0.00
- BIOA 76.06
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.